Represented by law firms with deep experience in insurance-coverage disputes, big companies are preparing for dragged-out legal fights over Covid-19 “business interruption” claims
Businesses suing insurers for billions in losses from Covid-19 shutdowns are entering a new phase: jury trials.
Over the past year, judges have ruled in favor of insurers in hundreds of cases, backing up the carriers’ rejections of Many of those rulings have involved policies with virus-specific exclusions, which can make the cases more open-and-shut for judges.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Weiterlesen »
Labor Groups Press for Biden’s Covid-19 Vaccine Mandate to Go FurtherThree labor organizations have filed petitions asking the Biden administration to review its Covid-19 vaccine mandate, with some indicating the policy is too limited in applying to only large businesses
Weiterlesen »
Why would anyone try to undo vaccinations after getting Covid-19 shots?Putting aside the fact that no one should want to de-vaccinate themselves, it's important to note that these efforts don't work.
Weiterlesen »
NHL pauses Ottawa Senators' season due to Covid-19 outbreakThe NHL has halted the Ottawa Senators' season for at least a week because of a Covid-19 outbreak in the team
Weiterlesen »
Sleep Disorders Could Raise the Risk of Severe COVID-19People with sleep disorders are no more likely than other adults to get infected with coronavirus and develop COVID-19. However, if infected, they are at a 31% higher risk of being hospitalized or dying from the illness, new research reveals:
Weiterlesen »
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
Weiterlesen »